Hypothesis

3 Matching Annotations

Feb 2026
www.biorxiv.org www.biorxiv.org

IL-6R blockade with tocilizumab disrupts pericyte– and tumor cell–driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer

1
1. scibot 05 Feb 2026
  
  in Public
  
  RRID:AB_3096062
  
  DOI: 10.64898/2026.01.29.702661
  
  Resource: (Selleck Cat# A2051, RRID:AB_3096062)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_3096062
  
  What is this?
  
  RRID:AB_3096062
Visit annotations in context

Tags

RRID:AB_3096062

Annotators

scibot

URL

biorxiv.org/content/10.64898/2026.01.29.702661v1
Nov 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

CD9 antibody enhances the anti-leukemia efficacy of γδT cells in adult B cell acute lymphoblastic leukemia

1
1. scibot 19 Nov 2025
  
  in Public
  
  RRID:AB_3096062
  
  DOI: 10.1016/j.isci.2025.113752
  
  Resource: (Selleck Cat# A2051, RRID:AB_3096062)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_3096062
  
  What is this?
  
  RRID:AB_3096062
Visit annotations in context

Tags

RRID:AB_3096062

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12616032/
Aug 2025
www.sciencedirect.com www.sciencedirect.com

Integrative genomic identification of therapeutic targets for pancreatic cancer

1
1. scibot 26 Aug 2025
  
  in Public
  
  RRID:AB_3096062
  
  DOI: 10.1016/j.celrep.2025.116191
  
  Resource: None
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_3096062
  
  What is this?
  
  RRID:AB_3096062
Visit annotations in context

Tags

RRID:AB_3096062

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124725009623